SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | 0.0% | 86 | -2.3% | 0.01% | 0.0% |
| Q2 2023 | $10 | -87.7% | 88 | -85.1% | 0.01% | -88.7% |
| Q1 2023 | $81 | -57.8% | 589 | -60.3% | 0.07% | -9.0% |
| Q4 2022 | $192 | -99.8% | 1,482 | +47.2% | 0.08% | -20.4% |
| Q3 2022 | $111,000 | +753.8% | 1,007 | +472.2% | 0.10% | +880.0% |
| Q2 2022 | $13,000 | -7.1% | 176 | -0.6% | 0.01% | +11.1% |
| Q1 2022 | $14,000 | +55.6% | 177 | +77.0% | 0.01% | -30.8% |
| Q4 2021 | $9,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |